Loading…
The US has imposed a 100% ad valorem duty on imports of certain patented pharmaceuticals and associated ingredients.
The Global Trade Research Initiative (GTRI) assesses that India's pharmaceutical exports to the US will be largely shielded from these tariffs.
This is because India primarily exports generic drugs to the US, which are not the target of the new duties.
The US policy aims to reduce domestic drug prices by targeting countries with lower patented drug costs.
An 'ad valorem duty' is a type of tariff or tax calculated as a percentage of the value of the goods or services. In contrast, a 'specific duty' is a fixed amount per unit. 'Patented drugs' are brand-name medications protected by intellectual property rights, granting the inventor exclusive rights for a period to recoup research and development costs. 'Generic drugs' are pharmaceutical products that are identical to a brand-name drug in dosage, safety, strength, route of administration, quality, performance, and intended use, but are sold after the patent on the original drug has expired, making them significantly cheaper.
Simple Analogy: Think of patented drugs as a newly launched smartphone model with exclusive features and a high price, protected by a patent. Generic drugs are like a similar phone model released by another company after the patent expires, offering the same functionality at a much lower price.
An independent Indian think tank focused on providing research, analysis, and policy recommendations on trade, investment, and technology issues.
This tariff is part of broader US efforts to influence global trade practices and reduce domestic costs, particularly in healthcare.
Highlights India's position as the 'pharmacy of the world' due to its robust generic drug manufacturing capabilities and its resilience to certain international trade pressures.
The distinction between patented and generic drugs is fundamentally linked to IPR, which governs the exclusive rights granted to innovators.
The US policy aims to lower drug prices domestically, reflecting a global debate on balancing pharmaceutical innovation with public access to affordable medicines.
GS Paper II: International Relations (Bilateral, regional and global groupings and agreements involving India and/or affecting India’s interests); GS Paper III: Economy (Effect of liberalization on the economy, changes in industrial policy and their effects on industrial growth), Science & Technology (Developments and their applications and effects in everyday life).
General Awareness (Indian Economy, International Organizations, Current Affairs).
General Awareness (Indian Economy, International Trade, Current Affairs).
Which of the following is/are the aim/aims of "Digital India" Plan of the Government of India? 1. Formation of India's own Internet companies like China did. 2. Establish a policy framework to encourage overseas multinational corporations that collect Big Data to build their large data centres within our national geographical boundaries. 3. Connect many of our villages to the Internet and bring Wi-Fi to many of our schools, public places and major tourist centres. Which of the statements given above is/are correct?
Answer: 3 only
With reference to solar power production in India, consider the following statements: 1. India is the third largest in the world in the manufacture of silicon wafers used in photovoltaic units. 2. The solar power tariffs are determined by the Solar Energy Corporation of India. Which of the statements given above is/are correct?
Answer: Neither 1 nor 2
Which of the following statements is/are correct regarding Smart India Hackathon 2017? 1. It is a centrally sponsored scheme for developing every city of our country into Smart Cities in a decade. 2. It is an initiative to identify new digital technology innovations for solving the many problems faced by our country. 3. It is a programme aimed at making all the financial transactions in our country completely digital in a decade. Select the correct answer using the code given below:
Answer: 2 only
Medium (International trade policies and their impact on India are recurring themes in competitive exams).
A tax or duty calculated as a percentage of the value of goods or services.
Pharmaceutical products bioequivalent to a brand-name drug but sold after patent expiry, typically at lower prices.
Brand-name drugs protected by intellectual property rights, granting exclusive manufacturing and sales rights for a period.
A US policy concept aimed at linking domestic drug prices to lower prices found in other developed countries.